In Brief: Barr warfarin
Executive Summary
Barr warfarin: Shipments of the generic version of DuPont Merck's Coumadin have begun, Barr announces July 28. Initial stocking orders of more than $10 mil. have been received. Barr expects to spend $5 mil. on promoting the product in 1997. The marketing program includes educational materials targeted to physicians, pharmacists and patients, as well as trade ads and direct mail. As a narrow therapeutic index drug, generic warfarin will face some brand-to-generic switch restrictions in Virginia, North Carolina and Texas. Barr's product was approved March 26 ("The Pink Sheet" March 31, p. 6)...